vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and Madison Square Garden Sports Corp. (MSGS). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $403.4M, roughly 1.2× Madison Square Garden Sports Corp.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 2.0%, a 4.8% gap on every dollar of revenue. On growth, Madison Square Garden Sports Corp. posted the faster year-over-year revenue change (12.8% vs -1.7%). Over the past eight quarters, Pediatrix Medical Group, Inc.'s revenue compounded faster (-0.1% CAGR vs -3.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
Madison Square Garden Sports Corp. is an American sports holding company based in New York City.
MD vs MSGS — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $403.4M |
| Net Profit | $33.7M | $8.2M |
| Gross Margin | — | — |
| Operating Margin | 9.9% | 5.5% |
| Net Margin | 6.8% | 2.0% |
| Revenue YoY | -1.7% | 12.8% |
| Net Profit YoY | 10.5% | 641.9% |
| EPS (diluted) | $0.40 | $0.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $403.4M | ||
| Q3 25 | $492.9M | $39.5M | ||
| Q2 25 | $468.8M | $204.0M | ||
| Q1 25 | $458.4M | $424.2M | ||
| Q4 24 | $502.4M | $357.8M | ||
| Q3 24 | $511.2M | $53.3M | ||
| Q2 24 | $504.3M | $227.3M | ||
| Q1 24 | $495.1M | $430.0M |
| Q4 25 | $33.7M | $8.2M | ||
| Q3 25 | $71.7M | $-8.8M | ||
| Q2 25 | $39.3M | $-1.8M | ||
| Q1 25 | $20.7M | $-14.2M | ||
| Q4 24 | $30.5M | $1.1M | ||
| Q3 24 | $19.4M | $-7.5M | ||
| Q2 24 | $-153.0M | $25.5M | ||
| Q1 24 | $4.0M | $37.9M |
| Q4 25 | 9.9% | 5.5% | ||
| Q3 25 | 13.8% | -69.5% | ||
| Q2 25 | 12.8% | -11.1% | ||
| Q1 25 | 7.0% | 7.6% | ||
| Q4 24 | 7.8% | 3.7% | ||
| Q3 24 | 6.6% | -15.5% | ||
| Q2 24 | -31.3% | 23.0% | ||
| Q1 24 | 3.2% | 18.5% |
| Q4 25 | 6.8% | 2.0% | ||
| Q3 25 | 14.5% | -22.3% | ||
| Q2 25 | 8.4% | -0.9% | ||
| Q1 25 | 4.5% | -3.4% | ||
| Q4 24 | 6.1% | 0.3% | ||
| Q3 24 | 3.8% | -14.1% | ||
| Q2 24 | -30.3% | 11.2% | ||
| Q1 24 | 0.8% | 8.8% |
| Q4 25 | $0.40 | $0.34 | ||
| Q3 25 | $0.84 | $-0.37 | ||
| Q2 25 | $0.46 | $-0.08 | ||
| Q1 25 | $0.24 | $-0.59 | ||
| Q4 24 | $0.37 | $0.05 | ||
| Q3 24 | $0.23 | $-0.31 | ||
| Q2 24 | $-1.84 | $1.07 | ||
| Q1 24 | $0.05 | $1.57 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $81.3M |
| Total DebtLower is stronger | $570.5M | — |
| Stockholders' EquityBook value | $865.9M | $-282.1M |
| Total Assets | $2.2B | $1.5B |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $81.3M | ||
| Q3 25 | $340.1M | $48.6M | ||
| Q2 25 | $224.7M | $144.6M | ||
| Q1 25 | $99.0M | $96.5M | ||
| Q4 24 | $229.9M | $107.8M | ||
| Q3 24 | $103.8M | $52.3M | ||
| Q2 24 | $19.4M | $89.1M | ||
| Q1 24 | $8.0M | $40.0M |
| Q4 25 | $570.5M | — | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $865.9M | $-282.1M | ||
| Q3 25 | $890.7M | $-294.2M | ||
| Q2 25 | $833.8M | $-281.4M | ||
| Q1 25 | $789.2M | $-283.4M | ||
| Q4 24 | $764.9M | $-273.1M | ||
| Q3 24 | $732.5M | $-277.5M | ||
| Q2 24 | $706.5M | $-266.3M | ||
| Q1 24 | $856.2M | $-294.0M |
| Q4 25 | $2.2B | $1.5B | ||
| Q3 25 | $2.2B | $1.5B | ||
| Q2 25 | $2.1B | $1.5B | ||
| Q1 25 | $2.0B | $1.5B | ||
| Q4 24 | $2.2B | $1.4B | ||
| Q3 24 | $2.1B | $1.4B | ||
| Q2 24 | $2.0B | $1.3B | ||
| Q1 24 | $2.2B | $1.4B |
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $32.4M |
| Free Cash FlowOCF − Capex | — | $31.6M |
| FCF MarginFCF / Revenue | — | 7.8% |
| Capex IntensityCapex / Revenue | — | 0.2% |
| Cash ConversionOCF / Net Profit | 3.39× | 3.94× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-480.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $32.4M | ||
| Q3 25 | $137.3M | $-85.0M | ||
| Q2 25 | $137.2M | $49.7M | ||
| Q1 25 | $-117.5M | $6.3M | ||
| Q4 24 | $133.0M | $61.8M | ||
| Q3 24 | $91.8M | $-26.2M | ||
| Q2 24 | $107.0M | $108.4M | ||
| Q1 24 | $-125.2M | $4.0M |
| Q4 25 | — | $31.6M | ||
| Q3 25 | — | $-85.3M | ||
| Q2 25 | — | $49.4M | ||
| Q1 25 | — | $3.9M | ||
| Q4 24 | — | $61.2M | ||
| Q3 24 | — | $-26.5M | ||
| Q2 24 | — | $108.0M | ||
| Q1 24 | — | $3.9M |
| Q4 25 | — | 7.8% | ||
| Q3 25 | — | -216.3% | ||
| Q2 25 | — | 24.2% | ||
| Q1 25 | — | 0.9% | ||
| Q4 24 | — | 17.1% | ||
| Q3 24 | — | -49.7% | ||
| Q2 24 | — | 47.5% | ||
| Q1 24 | — | 0.9% |
| Q4 25 | — | 0.2% | ||
| Q3 25 | — | 0.9% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 0.0% |
| Q4 25 | 3.39× | 3.94× | ||
| Q3 25 | 1.91× | — | ||
| Q2 25 | 3.49× | — | ||
| Q1 25 | -5.66× | — | ||
| Q4 24 | 4.36× | 55.61× | ||
| Q3 24 | 4.72× | — | ||
| Q2 24 | — | 4.25× | ||
| Q1 24 | -31.03× | 0.11× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
MSGS
| Event Related | $167.2M | 41% |
| Media Rights | $122.3M | 30% |
| Sponsorship Signage And Suite Licenses | $98.5M | 24% |
| League Distribution | $15.4M | 4% |
